Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis

BACKGROUND: A Phase I, single-center investigation found that 8 weeks of antimycobacterial therapy improved sarcoidosis FVC. Safety and efficacy assessments have not been performed in a multicenter cohort. RESEARCH QUESTION: The objective of this study was to determine the safety and efficacy of ant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Chest
Main Authors: Drake, Wonder P., Culver, Daniel A., Baughman, Robert P., Judson, Marc A., Crouser, Elliott D., James, W. Ennis, Ayers, Gregory D., Ding, Tan, Abel, Kenny, Green, Abena, Kerrigan, Amy, Sesay, Ahmed, Bernard, Gordon R.
Format: Artigo
Jezik:Inglês
Izdano: American College of Chest Physicians 2021
Teme:
Diffuse Lung Disease: Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129732/
https://ncbi.nlm.nih.gov/pubmed/33387486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.12.027
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki